MARKET

MGTX

MGTX

Meiragtx Holdings Plc
NASDAQ
11.11
+0.20
+1.83%
After Hours: 11.11 0 0.00% 19:30 09/28 EDT
OPEN
10.79
PREV CLOSE
10.91
HIGH
11.27
LOW
10.59
VOLUME
930.00K
TURNOVER
--
52 WEEK HIGH
15.35
52 WEEK LOW
6.62
MARKET CAP
1.07B
P/E (TTM)
15.74
1D
5D
1M
3M
1Y
5Y
1D
MeiraGTx: Promising Gene Therapy Platform but Early-Stage Risks Keep Risk/Reward Balanced at Hold
TipRanks · 3d ago
MeiraGTx (MGTX) Stock Could Look Stretched As Earnings Face Questions
Simply Wall St · 4d ago
MeiraGTx Holdings Price Target Announced at $16.00/Share by Goldman Sachs
Dow Jones · 4d ago
Goldman Sachs Initiates Coverage On MeiraGTx Holdings with Neutral Rating, Announces Price Target of $16
Benzinga · 4d ago
MeiraGTx initiated with a Neutral at Goldman Sachs
TipRanks · 4d ago
MeiraGTx Appoints Veteran Investor Alan Sebulsky to Board
TipRanks · 5d ago
MeiraGTx appoints Sebulsky to its Board of Directors
TipRanks · 5d ago
Press Release: MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors
Dow Jones · 5d ago
More
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.

Webull offers MeiraGTx Holdings PLC stock information, including NASDAQ: MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.